4-Aminopyridine is a promising treatment option for patients with gain-of-function KCNA2 -encephalopathy
The DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index.
Abstract
4-Aminopyridine is a potential therapeutic option for a subgroup of patients with KCNA2 -encephalopathy and gain-of-function variants.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Early Identification of Refractory Epilepsy
Kwan, P., & Brodie, M. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002033420503 · Cited by 5,204
Scheffer, I. E., Berkovic, S., Capovilla, G., Connolly, M. B., French, J., Guilhoto, L., Hirsch, E., Jain, S., Mathern, G. W., Moshé, S. L., et al. (2017) · Epilepsia · doi:10.1111/epi.13709 · Cited by 5,054
Fisher, R. S., Cross, J. H., French, J. A., Higurashi, N., Hirsch, E., Jansen, F. E., Lagae, L., Moshé, S. L., Peltola, J., Roulet Perez, E., et al. (2017) · Epilepsia · doi:10.1111/epi.13670 · Cited by 3,483
Wilson, I. B. (1995) · JAMA · doi:10.1001/jama.1995.03520250075037 · Cited by 3,027
Chen, Z., Brodie, M. J., Liew, D., & Kwan, P. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2017.3949 · Cited by 1,514
Gutman, G. A., Chandy, K. G., Grissmer, S., Lazdunski, M., Mckinnon, D., Pardo, L. A., Robertson, G. A., Rudy, B., Sanguinetti, M. C., Stühmer, W., et al. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.4.10 · Cited by 887
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
Kim, J., Hu, C., Moufawad El Achkar, C., Black, L. E., Douville, J., Larson, A., Pendergast, M. K., Goldkind, S. F., Lee, E. A., Kuniholm, A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1813279 · Cited by 827
The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?
Lillie, E. O., Patay, B., Diamant, J., Issell, B., Topol, E. J., & Schork, N. J. (2011) · Personalized Medicine · doi:10.2217/pme.11.7 · Cited by 706
Determining Optimal Therapy — Randomized Trials in Individual Patients
Guyatt, G., Sackett, D., Taylor, D. W., Ghong, J., Roberts, R., & Pugsley, S. (1986) · New England Journal of Medicine · doi:10.1056/nejm198604033141406 · Cited by 579
A phase 3 trial of extended release oral dalfampridine in multiple sclerosis
Goodman, A. D., Brown, T. R., Edwards, K. R., Krupp, L. B., Schapiro, R. T., Cohen, R., Marinucci, L. N., Blight, A. R., & on behalf of the MSF204 Investigators (2010) · Annals of Neurology · doi:10.1002/ana.22240 · Cited by 374
Research works printed but not linked: 1
- M. Msall, S. Braun, C. Granger, Use of the functional independence measure for children (WeeFIM): An interdisciplinary training tape. Dev. Med. Child Neurol. 32, 46–50 (1990).
Cited by
Developmental and epileptic encephalopathies: from genetic heterogeneity to phenotypic continuum
Guerrini, R., Conti, V., Mantegazza, M., Balestrini, S., Galanopoulou, A. S., & Benfenati, F. (2023) · Physiological Reviews · doi:10.1152/physrev.00063.2021 · Cited by 196
Developmental and epileptic encephalopathies
Scheffer, I. E., Zuberi, S., Mefford, H. C., Guerrini, R., & McTague, A. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00546-6 · Cited by 158
Knowles, J. K., Helbig, I., Metcalf, C. S., Lubbers, L. S., Isom, L. L., Demarest, S., Goldberg, E. M., George, A. L., Lerche, H., Weckhuysen, S., et al. (2022) · Epilepsia · doi:10.1111/epi.17332 · Cited by 166
Self-citationBackwell, L., & Marsh, J. A. (2022) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-111221-103208 · Cited by 136
Current practice in diagnostic genetic testing of the epilepsies
Krey, I., Platzer, K., Esterhuizen, A. I., Berkovic, S. F., Helbig, I., Hildebrand, M. S., Lerche, H., Lowenstein, D. H., Møller, R. S., Poduri, A., et al. (2022) · Epileptic Disorders · doi:10.1684/epd.2022.1448 · Cited by 127
Self-citation
Metadata
- Authors
- Hedrich, U. B. S., Lauxmann, S., Wolff, M., Synofzik, M., Bast, T., Binelli, A., Serratosa, J. M., Martínez-Ulloa, P., Allen, N. M., King, M. D., Gorman, K. M., Zeev, B. B., Tzadok, M., Wong-Kisiel, L., Marjanovic, D., Rubboli, G., Sisodiya, S. M., Lutz, F., Ashraf, H. P., Torge, K., Yan, P., Bosselmann, C., Schwarz, N., Fudali, M., & Lerche, H.
- Affiliations
- Hertie Institute for Clinical Brain Research (DE)
- Vivantes Klinikum (DE)
- German Center for Neurodegenerative Diseases (DE)
- University of Freiburg (DE)
- Hospital Pedro de Elizalde (AR)
- Centre for Biomedical Network Research on Rare Diseases (ES)
- Hospital Universitario Fundación Jiménez Díaz (ES)
- Ollscoil na Gaillimhe – University of Galway (IE)
- University College Dublin (IE)
- Tel Aviv University (IL)
- Divisions of Child Neurology & Division of Epilepsy, Department of Neurology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.
- Danish Epilepsy Center, Filadelfia, 4293 Dianalund, Denmark.
- University of Copenhagen (DK)
- UCL Queen Square Institute of Neurology (GB)
- University of Tübingen (DE)
- Corresponding author
- Hedrich, Ulrike B. S.
- Lauxmann, Stephan
- Lerche, Holger
- ORCID
- Hedrich, Ulrike B. S.
- Lauxmann, Stephan
- Wolff, Markus
- Synofzik, Matthis
- Bast, Thomas
- Binelli, Adrian
- Serratosa, José M.
- Allen, Nicholas M.
- Gorman, Kathleen M.
- Zeev, Bruria Ben
- Tzadok, Michal
- Wong-Kisiel, Lily
- Marjanovic, Dragan
- Rubboli, Guido
- Sisodiya, Sanjay M.
- Lutz, Florian
- Ashraf, Harshad Pannikkaveettil
- Bosselmann, Christian
- Schwarz, Niklas
- Fudali, Monika
- Lerche, Holger
- Venue
- Science Translational Medicine
- Published
- 2021-09
- Volume
- 13
- Issue
- 609
- Pages
- eaaz4957-eaaz4957
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W3196414892
- Cited by
- 87
- References
- 69
- Citations by year
- 2026: 10 · 2025: 24 · 2024: 18 · 2023: 21 · 2022: 11 · 2021: 3
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- DZNE Pub (submittedVersion)
- Funders
- National Institute for Health and Care Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- 4-aminopyridine, KCNA2, gain-of-function mutations, encephalopathy, potassium channelopathy, treatment selection
- MeSH terms
- Gain of Function Mutation, Brain Diseases, Epilepsy, Humans, Mutation, 4-Aminopyridine, Kv1.2 Potassium Channel
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 4-Aminopyridine is a promising treatment option for patients with gain-of-function KCNA2 -encephalopathy. https://app.cochat.ai/papers/10.1126/scitranslmed.aaz4957
- The paper
- Hedrich, U. B. S., Lauxmann, S., Wolff, M., Synofzik, M., Bast, T., Binelli, A., Serratosa, J. M., Martínez-Ulloa, P., Allen, N. M., King, M. D., Gorman, K. M., Zeev, B. B., Tzadok, M., Wong-Kisiel, L., Marjanovic, D., Rubboli, G., Sisodiya, S. M., Lutz, F., Ashraf, H. P., . . . Lerche, H. (2021). 4-Aminopyridine is a promising treatment option for patients with gain-of-function KCNA2 -encephalopathy. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aaz4957
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.